Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives $30.93 Average PT from Brokerages

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) have earned an average rating of “Hold” from the eight ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $30.9250.

A number of research firms have commented on SNN. Barclays cut shares of Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research note on Wednesday. Kepler Capital Markets cut Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research note on Thursday, June 4th. Weiss Ratings lowered Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, June 11th. Morgan Stanley reiterated an “overweight” rating on shares of Smith & Nephew SNATS in a report on Wednesday. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Smith & Nephew SNATS in a research report on Monday, May 25th.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in SNN. Perpetual Ltd purchased a new position in shares of Smith & Nephew SNATS in the fourth quarter worth $1,518,000. Teachers Retirement System of The State of Kentucky raised its holdings in Smith & Nephew SNATS by 31.8% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 599,500 shares of the medical equipment provider’s stock valued at $19,670,000 after buying an additional 144,800 shares during the last quarter. Deprince Race & Zollo Inc. boosted its position in Smith & Nephew SNATS by 10.6% during the 4th quarter. Deprince Race & Zollo Inc. now owns 375,955 shares of the medical equipment provider’s stock valued at $12,335,000 after buying an additional 36,072 shares during the period. Todd Asset Management LLC boosted its position in Smith & Nephew SNATS by 30.2% during the 4th quarter. Todd Asset Management LLC now owns 944,578 shares of the medical equipment provider’s stock valued at $30,992,000 after buying an additional 219,348 shares during the period. Finally, QRG Capital Management Inc. grew its holdings in Smith & Nephew SNATS by 29.4% in the 1st quarter. QRG Capital Management Inc. now owns 80,311 shares of the medical equipment provider’s stock worth $2,552,000 after acquiring an additional 18,251 shares during the last quarter. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Stock Down 1.0%

Shares of SNN opened at $30.14 on Monday. The company has a quick ratio of 1.25, a current ratio of 2.57 and a debt-to-equity ratio of 0.60. Smith & Nephew SNATS has a 1 year low of $28.56 and a 1 year high of $38.79. The business’s 50 day simple moving average is $30.45 and its 200-day simple moving average is $32.16.

Smith & Nephew SNATS Announces Dividend

The company also recently announced a dividend, which will be paid on Friday, November 6th. Shareholders of record on Friday, October 2nd will be paid a $0.312 dividend. The ex-dividend date of this dividend is Friday, October 2nd. This represents a yield of 205.0%.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.